Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreDeveloping IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreDeveloping IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreDeveloping IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreBringing together unparalleled healthcare data, advanced analytics, innovative technologies, and healthcare expertise to create intelligent connections that speed the development and commercialization of innovative medicines to improve patient lives.
Learn MoreAccelerate digital innovation to enable smarter decisions that reduce cost, modernize patient and consumer engagement, and improve health outcomes.
Learn MoreYour world is unique – and quite different from pharma. In the U.S., decision-making has shifted from individual physicians to integrated networks--GPOs, IDNs and payers. These groups have heightened the focus on proving your solution’s value, demanding outcomes analyses and putting pressure on pricing.
Learn MoreFor government agencies and organizations at every level—from federal or national to regional and local—Big Data can have a huge impact on public health.
Learn MoreA curation of IQVIA's best thinking on topics and trends driving change, disruption, and progress in the United States healthcare market.
LEARN MOREGet the latest insights on our life sciences, healthcare, and medical technology solutions in the United States. Follow our blog today!
LEARN MOREMDRP provides unparalleled access to the government regulators creating the rules, the industry leaders interpreting them, and the pharmaceutical executives implementing them.
The IQVIA U.S. Market Access team is a gold sponsor of this year's event and will be participating in several panel discussions:
How Inappropriate Utilization Changes Manufacturer Margins – Diane Weisbrod and Michael Holzbauer (presenters)
Tuesday, 9/24, 1:50 pm – 2:35 pm
Track C: 340B Policy and Process
Data Integrity Best Practices – Jake Keenan (moderator), Robyn Shramek (panelist)
Tuesday, 9/24, 4:35 pm – 5:20 pm
Track A: Calculation & Reporting Requirements: Challenges and Solutions
Medical Claims vs Pharmacy Claims – Lynn Lewis (panelist)
Wednesday, 9/25, 12:10 pm – 12:50 pm
Track F: Fundamentals of Rebate Operations & Disputes
Robotic Process Automation - Case Study of Success
Track D: Analytics and Technology
Tuesday, 24 September 2019 2:35pm – 3:20pm
Karl Ramas
Principal, Global Pricing and Contracting CoE
Eric Kalabacos
Sr. Principal, Global Pricing and Contracting CoE
Link : https://lifesciences.knect365.com/medicaid-drug-rebate/agenda/2#track-d-analytics-and-technology_robotic-process-automation-case-study-of-success